Full Press Release Details
SAN RAFAEL, Calif. , Oct. 31, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) today announced that management will participate in Credit Suisse's 26 th Annual Healthcare Conference on November 7, 2017 at 9:10am MT / 11:10am ET , in Scottsdale, Arizona , the Stifel 2017 Healthcare Conference on November 14, 2017 at 10:15am ET in New York and the Evercore ISI Biopharma Catalyst/Deep Dive Conference on November 29, 2017 at 11:00am ET in Boston. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com . A replay will also be archived on the site for at least one week following each event.
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com . Information on BioMarin's website is not incorporated by reference into this press release.
| Contacts: | |
| Investors | Media |
| Traci McCarty | Debra Charlesworth |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
| (415) 455-7558 | (415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.